Cefixime composition and preparation method thereof

A technology of cefixime and cefixime oral preparations, which is applied in the field of cefixime composition and its preparation, can solve the problems of organic solvent residue, uneven content, and reduced dissolution rate, and achieve high mixing uniformity and particle size Uniform, stability-enhancing effect

Active Publication Date: 2014-07-30
HAINAN RIZHONGTIAN PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For wet granulation, due to the instability of cefixime to heat and humidity, cefixime is often degraded during the preparation process, resulting in an increase in the content of related substances, which affects the safety of the drug
However, dry granulation can make the material not well mixed, and the particle size of the oral preparation is not uniform, resulting in a decrease in dissolution rate
In addition, there are currently other schemes for preparing cefixime oral preparations: for example, some technical schemes take raw materials and mix and pulverize them and then directly fill them into capsules, but this scheme usually leads to uneven content due to the difficulty in controlling the capsule loading, while some Technical solution During the preparation process, organic solvents such as methanol are used to dissolve cefixime, but there will be residues of organic solvents in the prepared product, which will affect the safety of the drug.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefixime composition and preparation method thereof
  • Cefixime composition and preparation method thereof
  • Cefixime composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The preparation of embodiment 1 cefixime composition

[0023] Take the components:

[0024]

[0025] The above-mentioned 15g of liquid paraffin and 15g of magnesium stearate were mixed evenly to make it semi-solid, and 200g of cefixime was added and mixed through a 40-mesh sieve for 3 times. Add 200g of cefixime and mix well. Add 1215g of dry starch and mix evenly to get final product.

Embodiment 2

[0026] The preparation of embodiment 2 cefixime composition

[0027] Take the components:

[0028]

[0029] The above-mentioned 20g of liquid paraffin and 10g of magnesium stearate were mixed evenly to make it semi-solid, and 180g of cefixime was added and mixed through a 40-mesh sieve for 3 times. Add 180g of cefixime and mix well. Add 1500g of dry starch and mix evenly to get ready.

Embodiment 3

[0030] The preparation of embodiment 3 cefixime composition

[0031] Take the components:

[0032]

[0033] The above-mentioned 10g of liquid paraffin and 50g of magnesium stearate were mixed evenly to make it semi-solid, and 220g of cefixime was added and mixed through a 40-mesh sieve for 3 times. Add 220g of cefixime and mix well. Add 1100g of dry starch and mix evenly to get ready.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicines, and particularly relates to a cefixime composition and a preparation method thereof. The cefixime composition comprises the following components in parts by weight: 360-440 parts of cefixime, 10-20 parts of liquid paraffin, 10-50 parts of magnesium stearate and 1100-1500 parts of dry starch. In the cefixime composition provided by the invention, the liquid paraffin has the effects of improving the stability of the composition, reducing the content of impurities in the composition and also promoting the dispersion of the cefixime, so that the dissolution rate of an oral preparation is increased. Experiments show that after the cefixime composition provided by the invention is prepared into the oral preparation, the dissolution rate is above 97% at the thirtieth minute and can be above 99%; an acceleration experiment and a long-term experiment show that the oral preparation prepared from the cefixime composition provided by the invention has small content changes after being preserved for six months, so the composition is proved to be stable in nature.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a cefixime composition and a preparation method thereof. Background technique [0002] Cefixime, the English name is Cefixime, the Chinese aliases are acetioxime cephalosporin, Shifusu granules, and the CAS number is 79350-37-1. It is a third-generation cephalosporin antibiotic and is absorbed through the gastrointestinal tract when taken orally. Finally, it can prevent the synthesis of bacterial cell walls and play an antibacterial effect, which is safe, efficient and resistant to enzymes. Cefixime is white to light yellow crystalline powder, bitter and slightly specific odor, unstable to damp heat, easily soluble in methanol and dimethyl sulfoxide, slightly soluble in acetone, hardly soluble in ethanol, almost insoluble in water, Ethyl acetate, ether, hexane. [0003] At present, oral preparations of cefixime mainly include tablets, dispersible tablets, dry suspensions and capsules. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/44A61K47/12A61K31/546A61P31/04
Inventor 张光春舒军郭荣芳庄太能罗乐吴孟云
Owner HAINAN RIZHONGTIAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products